A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis
Veterinary Dermatology.
MeSH headings : Dogs; Animals; Dermatitis, Atopic / drug therapy; Dermatitis, Atopic / veterinary; Dermatitis, Atopic / complications; Prednisolone / therapeutic use; Dermatologic Agents; Pruritus / veterinary; Dog Diseases / pathology; Immunoglobulin A / therapeutic use
TL;DR:
The initial addition of 4 days of prednisolone significantly decreased the probability of a rebound of pruritus 1 week after oclacitinib dose reduction, and this short concomitant glucocorticoid administration led to a higher skin lesion improvement and improved perception of treatment efficacy with minimal adverse effects.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories